02:10 PM EST, 01/27/2025 (MT Newswires) -- Health care stocks rose Monday afternoon, with the NYSE Health Care Index adding 2% and the Health Care Select Sector SPDR Fund (XLV) up 2.1%.
The iShares Biotechnology ETF (IBB) rose 0.7%.
In corporate news, Walgreens Boots Alliance ( WBA ) shares fell 6.4% after CNBC's David Faber reported the company's talks with Sycamore Partners on a go-private deal are "mostly dead," according to media reports.
Sage Therapeutics ( SAGE ) said Monday its board rejected Biogen's (BIIB) unsolicited, non-binding proposal to buy Sage shares not already owned by Biogen for $7.22 per share. Sage shares rose 4.8% and Biogen was adding 1.8%.
Allakos ( ALLK ) said Monday its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and that its development will be terminated immediately. Its shares dropped 78%.